Evidence map›Paper›PMID 41989563›Full record

ReviewArchives of microbiology2026

The gut microbiome axis: how Lactobacillus-fermented soymilk orchestrates health.

Vaishali Saini, Arpit Verma, Samlesh Kumari, Sandeep Chaudhary, Amit Mishra, Awanish Kumar, Hem Chandra Jha

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vaishali SainiInfection Bioengineering Group, POD 1B-602, Mehta Family School of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, Madhya Pradesh, 453552, India.
Arpit VermaInfection Bioengineering Group, POD 1B-602, Mehta Family School of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, Madhya Pradesh, 453552, India.
Samlesh KumariCentre of Excellence on Soybean Processing and Utilization (CESPU), ICAR-Central Institute of Agricultural Engineering, Nabibagh, Bhopal, Madhya Pradesh, 462038, India.
Sandeep ChaudharyDepartment of Civil Engineering, Indian Institute of Technology Indore, Simrol, Indore, 453552, India.
Amit MishraCellular and Molecular Neurobiology Unit, Indian Institute of Technology, Jodhpur, Rajasthan, India.
Awanish KumarDepartment of Biotechnology, National Institute of Technology, Raipur, Chhattisgarh, 492010, India.
Hem Chandra JhaInfection Bioengineering Group, POD 1B-602, Mehta Family School of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, Madhya Pradesh, 453552, India. hemcjha@iiti.ac.in.

Funding

Anusandhan National Research Foundation (IN) ANRF/PAIR/2025/000018/PAIR-A(G)CRDT-IIT Indore IITI/CRDT/2022-23/05PMRF (IN) 2103365
6 · The paper itself

Abstract

Human culinary traditions have been deeply rooted in the consumption of fermented food products, offering health-promoting benefits. Among these, soymilk fermentation by lactic acid bacteria emerges as a captivating opportunity to produce enhanced soy-based flavor profiles with extended nutritional value. Among the numerous advantages, components of soymilk, such as isoflavone aglycones and peptides, show a hypolipidemic effect, thus proving beneficial to humans. Of central interest is Lactobacillus, a well-studied probiotic genus that exerts a pivotal role in the maintenance of gut barrier and microbial diversity. The interplay between gut microbiome and host physiology underscores its role in health and disease. Gut dysbiosis results from the interaction of environmental cues with host metabolic state, triggering pathological consequences. These range from irritable bowel syndrome and gastric cancer to neurological disorders. This review attempts to evaluate the knowledge surrounding fermented soymilk to shed light on the vital role of Lactobacillus in restoring a dysbiotic state within the gut microbiome. Further, we elucidate multifaceted mechanisms underlying the therapeutic potential of Lactobacillus-fermented soymilk. By exploring this complex interplay of microbial metabolites and host immune responses, and incorporating recent advancements in probiotic therapeutics, we emphasize the utilization of Lactobacillus-fermented soymilk as a dietary intervention to promote gut health and alleviate disease states.

Indexed as

Gastrointestinal MicrobiomeLactobacillusSoy MilkAnimalsDysbiosisFermentationFermented FoodsHumansProbioticsFermentationGut healthGut microbiomeLactic acid bacteriaSoymilk

Identifiers

PMID41989563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.